US judge rejects FTC's bid to block private equity medical company deal
Nov 10 (Reuters) - Private equity firm GTCR can move forward with its acquisition of medical device coatings maker Surmodics' SRDX.O, a federal judge in Chicago ruled on Monday, rejecting the U.S. Federal Trade Commission's bid to block the deal. The FTC sued to block the deal in March in its first lawsuit to block a merger during President Donald Trump's second term. (Reporting by Jody Godoy in New York; Editing by Chris Reese) ((jody.godoy@tr.com))
Recent news on SurModics
See all newsU.S. STOCKS ON THE MOVE-Surmodics, Cheniere Energy, American Public Education
U.S. STOCKS ON THE MOVE-Surmodics, Energy stocks, American Public Education
Surmodics jumps after US judge rejects FTC's bid to block acquisition by GTCR
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions